| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Revenues | ||||||
Total revenues | ||||||
959 | - | |||||
Cost of product sales | ||||||
453 | - | |||||
Gross (loss) profit | ||||||
506 | - | |||||
Operating expenses: | ||||||
Research and development | ||||||
11,555 | 5,627 | |||||
General and administrative | ||||||
7,552 | 4,694 | |||||
Total operating expenses | ||||||
19,107 | 10,321 | |||||
Loss from operations | ||||||
-18,601 | -10,321 | |||||
Other (expense) income: | ||||||
Interest and other income, net | ||||||
281 | 164 | |||||
Change in fair value of warrant liability | ||||||
- | 2,583 | |||||
Loss before income tax expense | ||||||
-18,320 | -12,740 | |||||
Net loss | ||||||
-18,320 | -12,740 | |||||
Accrued dividends on redeemable convertible preferred stock | ||||||
- | 1,048 | |||||
Deemed dividends for accretion of redeemable convertible preferred stock issuance costs | ||||||
- | 1,694 | |||||
Deemed dividends for beneficial conversion feature of redeemable convertible preferred stock | ||||||
- | -21,747 | |||||
Net loss attributable to common stockholders | ||||||
-18,320 | -37,229 | |||||
Net loss per share, basic and diluted | ||||||
-1.03 | -5.80 | |||||
Weighted average number of common shares outstanding, basic and diluted | ||||||
17,761 | 6,418 | |||||
Product Sales [Member] | ||||||
Total revenues | ||||||
459 | - | |||||
Licensing Revenue [Member] | ||||||
Total revenues | ||||||
500 | - | |||||